CARDIFF ONCOLOGY, INC. Increase (Decrease) in Other Operating Assets
CARDIFF ONCOLOGY, INC. (CRDF) reported Increase (Decrease) in Other Operating Assets of $378.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $83.00K, a 42.36% decline year-over-year.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $295.00K, a 56.91% increase year-over-year.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $148.00K.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for fiscal 2025 was $480.00K.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for fiscal 2024 was -$1.21M.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for fiscal 2023 was -$108.00K, a 109.41% decline from fiscal 2022.
- CARDIFF ONCOLOGY, INC. increase (decrease) in other operating assets for fiscal 2022 was $1.15M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed | Increase (Decrease) in Other Operating Assets 152 month | Increase (Decrease) in Other Operating Assets 155 month | Increase (Decrease) in Other Operating Assets 158 month | Increase (Decrease) in Other Operating Assets 161 month | Increase (Decrease) in Other Operating Assets 164 month | Increase (Decrease) in Other Operating Assets 167 month | Increase (Decrease) in Other Operating Assets 170 month | Increase (Decrease) in Other Operating Assets 173 month | Increase (Decrease) in Other Operating Assets 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $378.00K 10-Q · filed 2026-08-11 | $378.00K derived: sum of 3 quarters · filed 2026-08-11 | $526.00K derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2026-03-31 | $295.00K 10-Q · filed 2026-05-14 | $295.00K derived: sum of 2 quarters · filed 2026-05-14 | $443.00K derived: sum of 3 quarters · filed 2026-05-14 | $587.00K derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $148.00K derived: sum of 2 quarters · filed 2026-02-24 | $292.00K derived: sum of 3 quarters · filed 2026-08-11 | $480.00K 10-K · filed 2026-02-24 | |||||||||||||
| 2025-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $292.00K derived: sum of 2 quarters · filed 2026-08-11 | $480.00K 10-Q · filed 2025-11-06 | -$718.00K derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $332.00K 10-Q · filed 2026-08-11 | -$866.00K derived: sum of 3 quarters · filed 2026-08-11 | -$870.00K derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-03-31 | $188.00K 10-Q · filed 2026-05-14 | -$1.01M derived: sum of 2 quarters · filed 2026-05-14 | -$1.01M derived: sum of 3 quarters · filed 2026-05-14 | -$1.02M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.20M derived: sum of 2 quarters · filed 2026-02-24 | -$1.21M derived: sum of 3 quarters · filed 2026-02-24 | -$1.21M 10-K · filed 2026-02-24 | |||||||||||||
| 2024-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.00K derived: sum of 2 quarters · filed 2025-11-06 | -$12.00K 10-Q · filed 2025-11-06 | -$120.00K derived: sum of 4 quarters · filed 2025-11-06 | |||||||||||||
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$8.00K 10-Q · filed 2025-07-29 | -$116.00K derived: sum of 3 quarters · filed 2025-07-29 | -$119.00K derived: sum of 4 quarters · filed 2025-07-29 | |||||||||||||
| 2024-03-31 | -$4.00K 10-Q · filed 2025-05-08 | -$112.00K derived: sum of 2 quarters · filed 2025-05-08 | -$115.00K derived: sum of 3 quarters · filed 2025-05-08 | -$86.00K derived: sum of 4 quarters · filed 2025-05-08 | |||||||||||||
| 2023-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$111.00K derived: sum of 2 quarters · filed 2025-02-27 | -$82.00K derived: sum of 3 quarters · filed 2025-02-27 | -$108.00K 10-K · filed 2025-02-27 | |||||||||||||
| 2023-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $26.00K derived: sum of 2 quarters · filed 2024-08-08 | $0.00 10-Q · filed 2023-11-02 | $1.20M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.00K 10-Q · filed 2024-08-08 | $1.21M derived: sum of 3 quarters · filed 2024-08-08 | $1.21M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-03-31 | -$26.00K 10-Q · filed 2024-05-02 | $1.18M derived: sum of 2 quarters · filed 2024-05-02 | $1.18M derived: sum of 3 quarters · filed 2024-05-02 | $1.17M derived: sum of 4 quarters · filed 2024-05-02 | |||||||||||||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.20M derived: sum of 2 quarters · filed 2024-02-29 | $1.20M derived: sum of 3 quarters · filed 2024-02-29 | $1.15M 10-K · filed 2024-02-29 | |||||||||||||
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$4.00K derived: sum of 2 quarters · filed 2023-11-02 | -$55.00K 10-Q · filed 2023-11-02 | $40.00K derived: sum of 4 quarters · filed 2023-11-02 | |||||||||||||
| 2022-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$54.00K 10-Q · filed 2023-08-09 | $41.00K derived: sum of 3 quarters · filed 2023-08-09 | -$79.00K derived: sum of 4 quarters · filed 2023-08-09 | |||||||||||||
| 2022-03-31 | -$51.00K 10-Q · filed 2023-05-04 | $44.00K derived: sum of 2 quarters · filed 2023-05-04 | -$76.00K derived: sum of 3 quarters · filed 2023-05-04 | -$51.00K derived: sum of 4 quarters · filed 2023-05-04 | |||||||||||||
| 2021-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$25.00K derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | -$166.00K 10-K · filed 2023-03-02 | |||||||||||||
| 2021-09-30 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$95.00K derived: sum of 2 quarters · filed 2022-11-03 | -$261.00K 10-Q · filed 2022-11-03 | -$13.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||||||||||
| 2021-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$141.00K 10-Q · filed 2022-08-04 | $107.00K derived: sum of 3 quarters · filed 2022-08-04 | $110.00K derived: sum of 4 quarters · filed 2022-08-04 | |||||||||||||
| 2021-03-31 | -$166.00K 10-Q · filed 2022-05-05 | $82.00K derived: sum of 2 quarters · filed 2022-05-05 | $85.00K derived: sum of 3 quarters · filed 2022-05-05 | $81.00K derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||||
| 2020-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $251.00K derived: sum of 2 quarters · filed 2022-02-24 | $247.00K derived: sum of 3 quarters · filed 2022-02-24 | $246.00K 10-K · filed 2022-02-24 | $246.66K 10-K · filed 2021-02-25 | ||||||||||||
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.00K derived: sum of 2 quarters · filed 2021-11-04 | -$2.00K 10-Q · filed 2021-11-04 | -$1.81K 10-Q · filed 2020-11-05 | -$15.37K derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||||
| 2020-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$5.00K 10-Q · filed 2021-08-05 | -$4.99K 10-Q · filed 2020-08-11 | -$18.37K derived: sum of 3 quarters · filed 2021-08-05 | $17.31K derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||
| 2020-03-31 | -$1.00K 10-Q · filed 2021-05-06 | -$1.21K 10-Q · filed 2020-05-07 | -$14.37K derived: sum of 2 quarters · filed 2021-05-06 | $21.31K derived: sum of 3 quarters · filed 2021-05-06 | $69.50K derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | -$13.37K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $22.31K derived: sum of 2 quarters · filed 2021-02-25 | $70.50K derived: sum of 3 quarters · filed 2021-02-25 | $54.78K 10-K · filed 2021-02-25 | |||||||||||||
| 2019-09-30 | $35.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $83.87K derived: sum of 2 quarters · filed 2020-11-05 | $68.14K 10-Q · filed 2020-11-05 | -$78.70K derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||||
| 2019-06-30 | $48.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $32.46K 10-Q · filed 2020-08-11 | -$114.38K derived: sum of 3 quarters · filed 2020-08-11 | -$143.52K derived: sum of 4 quarters · filed 2020-08-11 | |||||||||||||
| 2019-03-31 | -$15.72K 10-Q · filed 2020-05-07 | -$162.57K derived: sum of 2 quarters · filed 2020-05-07 | -$191.71K derived: sum of 3 quarters · filed 2020-05-07 | $8.03K derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | -$146.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$175.99K derived: sum of 2 quarters · filed 2020-02-27 | $23.75K derived: sum of 3 quarters · filed 2020-02-27 | $23.75K 10-K · filed 2020-02-27 | |||||||||||||
| 2018-09-30 | -$29.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $170.60K derived: sum of 2 quarters · filed 2019-11-07 | $170.60K 10-Q · filed 2019-11-07 | $170.60K derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||
| 2018-06-30 | $199.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $199.74K 10-Q · filed 2019-08-08 | $199.74K derived: sum of 3 quarters · filed 2019-08-08 | $199.74K derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2019-05-07 | $0.00 derived: sum of 3 quarters · filed 2019-05-07 | $0.00 derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | $792.50K derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | $792.50K derived: sum of 3 quarters · filed 2018-08-03 | $792.50K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $792.50K derived: sum of 2 quarters · filed 2018-02-26 | $792.50K derived: sum of 3 quarters · filed 2018-02-26 | $792.50K derived: sum of 4 quarters · filed 2018-02-26 | |||||||||||||
| 2016-12-31 | $792.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $792.50K derived: sum of 2 quarters · filed 2018-02-26 | $792.50K derived: sum of 3 quarters · filed 2018-02-26 | $789.74K 10-K · filed 2018-02-26 | |||||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | -$2.76K 10-Q · filed 2017-11-09 | $24.26K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$2.76K 10-Q · filed 2017-08-09 | $24.26K derived: sum of 3 quarters · filed 2017-08-09 | $8.30K derived: sum of 4 quarters · filed 2017-08-09 | |||||||||||||
| 2016-03-31 | -$2.76K 10-Q · filed 2017-05-10 | $24.26K derived: sum of 2 quarters · filed 2017-05-10 | $8.30K derived: sum of 3 quarters · filed 2017-05-10 | $34.53K derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||
| 2015-12-31 | $27.02K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $11.06K derived: sum of 2 quarters · filed 2017-03-15 | $37.30K derived: sum of 3 quarters · filed 2017-03-15 | $37.30K 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | -$15.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $10.27K derived: sum of 2 quarters · filed 2016-11-09 | $10.27K 10-Q · filed 2016-11-09 | $79.00 derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-06-30 | $26.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $26.24K 10-Q · filed 2016-08-04 | $16.04K derived: sum of 3 quarters · filed 2017-03-15 | $16.04K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | -$10.19K derived: sum of 2 quarters · filed 2017-03-15 | -$10.19K derived: sum of 3 quarters · filed 2017-03-15 | ||||||||||||||
| 2014-12-31 | -$10.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$10.19K derived: sum of 2 quarters · filed 2017-03-15 | $258.00 10-K · filed 2017-03-15 | ||||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $10.45K 10-Q · filed 2015-11-09 | |||||||||||||||
| 2014-06-30 | $10.45K 10-Q · filed 2015-08-10 | ||||||||||||||||
| 2014-03-31 | $44.25K 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | -$75.46K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$194.16K derived: sum of 2 quarters · filed 2016-03-10 | -$182.32K derived: sum of 3 quarters · filed 2016-03-10 | -$25.63K 10-K · filed 2016-03-10 | $44.25K 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | -$118.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$106.86K derived: sum of 2 quarters · filed 2014-11-06 | $49.83K 10-Q · filed 2014-11-06 | $119.71K 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $11.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $168.53K 10-Q · filed 2014-08-07 | $238.41K 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | $156.69K 10-Q · filed 2014-05-12 | $226.57K 10-Q · filed 2013-05-14 | |||||||||||||||
| 2012-12-31 | $69.88K 10-K · filed 2013-04-01 | ||||||||||||||||
| 2012-09-30 | $69.88K 10-Q · filed 2012-11-14 | ||||||||||||||||
| 2012-06-30 | $69.88K 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | $69.88K 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$10.82K derived: sum of 2 quarters · filed 2014-03-17 | -$32.47K derived: sum of 3 quarters · filed 2014-03-17 | -$21.65K 10-K · filed 2014-03-17 | |||||||||||||
| 2011-09-30 | -$10.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$32.47K derived: sum of 2 quarters · filed 2012-11-14 | -$21.65K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | -$21.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$10.82K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $10.82K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |